AU4722099A - Inhibition of NF-kappaB mediated tissue injury using dithiocarbamate derivatives - Google Patents

Inhibition of NF-kappaB mediated tissue injury using dithiocarbamate derivatives

Info

Publication number
AU4722099A
AU4722099A AU47220/99A AU4722099A AU4722099A AU 4722099 A AU4722099 A AU 4722099A AU 47220/99 A AU47220/99 A AU 47220/99A AU 4722099 A AU4722099 A AU 4722099A AU 4722099 A AU4722099 A AU 4722099A
Authority
AU
Australia
Prior art keywords
inhibition
tissue injury
mediated tissue
dithiocarbamate derivatives
kappab mediated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU47220/99A
Inventor
Edward M. Boyle
Timothy O. Canty Jr.
John C. Kovacich
Elizabeth Morgan
Frank Norbert
Timothy H. Pohlman
Edward D. Verrier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Original Assignee
University of Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington filed Critical University of Washington
Publication of AU4722099A publication Critical patent/AU4722099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU47220/99A 1998-06-26 1999-06-24 Inhibition of NF-kappaB mediated tissue injury using dithiocarbamate derivatives Abandoned AU4722099A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10597698A 1998-06-26 1998-06-26
US09105976 1998-06-26
PCT/US1999/014490 WO2000000192A1 (en) 1998-06-26 1999-06-24 INHIBITION OF NF-λB MEDIATED TISSUE INJURY USING DITHIOCARBAMATE DERIVATIVES

Publications (1)

Publication Number Publication Date
AU4722099A true AU4722099A (en) 2000-01-17

Family

ID=22308801

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47220/99A Abandoned AU4722099A (en) 1998-06-26 1999-06-24 Inhibition of NF-kappaB mediated tissue injury using dithiocarbamate derivatives

Country Status (2)

Country Link
AU (1) AU4722099A (en)
WO (1) WO2000000192A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6747061B2 (en) 2000-03-21 2004-06-08 Atherogenics, Inc. N-substituted dithiocarbamates for the treatment of biological disorders
WO2001085175A2 (en) * 2000-05-11 2001-11-15 Oklahoma Medical Research Foundation Prevention of insulin-dependent diabetes, complications thereof, or allograft rejection by inhibition of cyclooxygenase-2 activity with ns398 or pdtc
CN116421594A (en) * 2022-01-04 2023-07-14 中南大学 NLRP3 inflammatory corpuscle inhibitor and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380747A (en) * 1992-10-30 1995-01-10 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
US5821260A (en) * 1992-10-30 1998-10-13 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases

Also Published As

Publication number Publication date
WO2000000192A9 (en) 2000-09-21
WO2000000192A1 (en) 2000-01-06

Similar Documents

Publication Publication Date Title
EP1059067B8 (en) Ablation treatment of bone metastases
AU2557397A (en) Removal of tissue
AU7298796A (en) Forceps for the surgical introduction of catheters and the like
AU3064699A (en) Dynamic orthopedic braces
AU4067800A (en) Surgical bone screw
AU1601695A (en) Photochemical ablation of gastro-intestinal tissue
AU1621499A (en) Thrombus macerator catheter
AU2270597A (en) Method of sterilization of bone tissue
AUPP260798A0 (en) Treatment of medical related conditions with isoflavone containing extracts of clover
AUPQ246799A0 (en) Surgical screw and guidewire
EP0784992A3 (en) Treatment device for malignant changes of tissue
AU4158599A (en) Surgical implant
AU5908300A (en) Prevention and treatment of amyloid-associated disorders
AU1556497A (en) Agents for the treatment and prevention of aids
AU6330999A (en) Rhodanine derivatives for the treatment and prevention of metabolic bone disorders
AU6274299A (en) Inhibition of pak activation of raf-1
AU1697197A (en) Immunoconjugate for the treatment of aids
AU1742200A (en) Prevention and treatment of amyloid-associated disorders
AU1878201A (en) Composition for the treatment of damaged tissue
AU7106300A (en) Treatment of skin disorders
AU4722099A (en) Inhibition of NF-kappaB mediated tissue injury using dithiocarbamate derivatives
AU6331099A (en) Thiazolidine derivatives for the treatment and prevention of metabolic bone disorders
AU8054198A (en) Disposable pant-type diaper having enhanced extensibility around waist opening
AU6366299A (en) Surgical suture
AU3760900A (en) Treatment of menstrual function

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase